# POINT Biopharma Global Inc.

POINT Biopharma Global Inc. is a company headquartered in Indianapolis, IN, United States.

## Company overview

- **Legal name:** POINT Biopharma Global Inc.
- **Former names in filing history:** Therapeutics Acquisition Corp. (2020-05-14 to 2021-06-30)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Indianapolis, IN, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001811764

## About

POINT Biopharma Global Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001811764, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-27, it reported annual revenue of USD 226,579,563; net income of USD 98,293,213; total assets of USD 578,322,736 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $226.6M (USD 226,579,563)
- **Net income:** $98.3M (USD 98,293,213)
- **Total assets:** $578.3M (USD 578,322,736)
- **Cash and equivalents:** $286.4M (USD 286,428,371)
- **Operating cash flow:** $183.5M (USD 183,518,622)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$45.9M (USD -45,902,481)
- **Total assets:** $263.3M (USD 263,258,642)
- **Cash and equivalents:** $238.8M (USD 238,815,991)
- **Operating cash flow:** -$44.7M (USD -44,698,758)

## Recent SEC filings

- Form 8-K — filed 2023-12-27 — period 2023-12-22 — FORM 8-K
- Form 10-Q — filed 2023-11-13 — period 2023-09-30 — 10-Q
- Form SC 13D — filed 2023-11-06 — SCHEDULE 13D
- Form 8-K — filed 2023-10-03 — period 2023-10-02 — FORM 8-K
- Form 10-Q — filed 2023-08-14 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-14 — period 2023-08-14 — 8-K
- Form 8-K — filed 2023-08-03 — period 2023-07-28 — 8-K
- Form 8-K — filed 2023-06-13 — period 2023-06-12 — 8-K
- Form 8-K — filed 2023-06-05 — period 2023-06-01 — 8-K
- Form 10-Q — filed 2023-05-15 — period 2023-03-31 — 10-Q
- Form DEF 14A — filed 2023-04-27 — period 2023-04-27 — DEF 14A
- Form 10-K — filed 2023-03-27 — period 2022-12-31 — 10-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/point-biopharma-global-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology